Lallemand contributes to the unprecedented global COVID-19 vaccination campaign via the COVAX Facility with a $US 100,000 donation to UNICEF Canada. With…
Lallemand Health Solutions has gained new indications for its documented EXPERT’Biotic™ L. helveticus Lafti® L10 from Health Canada recognizing its antioxidant properties,…
Lallemand Health Solutions and Aventus Innovations have signed a global agreement to grant Lallemand exclusive use of Aventus’ flagship technology, NutraJIT®, for…
As a platinum sponsor, The Rosell® Institute for Microbiome and Probiotics by Lallemand will join forces with the organizers to promote “Having…
Lallemand Health Solutions’ Probiokid®, the world’s best-selling pediatric probiotic formulation, makes the scientific news with its most recent review: “Efficacy of a…
As a co-founding partner of Mind, Mood & Microbes, Lallemand Health Solutions invites you to register to this third edition of the…
On Friday, April 23 took place, virtually, the 11th edition of the Scientific Exchange (SciEx), organized by Thomas A. Tompkins, Ph.D., Research…
Lallemand Health Solutions’ R&D Director for Microbiome Program and Bioprocess and Galenic Center, Sylvie Binda, together with IPA colleagues have cowritten a…
Thomas A. Tompkins, Ph.D., Research Director at the Rosell® Institute from Microbiome and Probiotics by Lallemand, is proud to be joining the…
Lallemand Health Solutions and Nimble Science are proud to officially kick-off the first North American clinical study of Nimble’ Small Intestine Microbiome…
